StoneX Group
XERS icon

StoneX Group’s Xeris Biopharma Holdings XERS Stock Holding History

StoneX Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$127K Buy
+14,832
New +$125K ﹤0.01% 1461

Other funds holding XERS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vilga Financial Planning
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

StoneX Group's XERS Position: Q3 2026 in Review

StoneX Group opened a new position in Xeris Biopharma Holdings (XERS) in Q3 2026: 14,832 shares worth $127K. The stake represents ﹤0.01% of the portfolio and ranks #1461 among its holdings.

104 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • StoneX Group held 14,832 shares of Xeris Biopharma Holdings worth $127K as of Q3 2026.
  • Xeris Biopharma Holdings was a new StoneX Group position in Q3 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1461 holding.
  • 104 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.